CClinicalTrials.gg
CompletedNCT04786691Updated Mar 23, 2023Results posted

How do You Take Your Coffee Before Anesthesia

An interventional study of Addition of half and half to coffee and Addition of non-dairy creamer to coffee in Anesthesia, Aspiration and Fasting, sponsored by University of Arkansas. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-23.

Sponsored by University of Arkansas · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Undergoing anesthesia requires patients to fast pre-operatively to allow the stomach to empty and prevent aspiration pneumonia but patients are allowed to drink "clear" liquids up to 2 hours before surgery. Clear liquids are defined as water, carbonated sodas, black coffee or tea without milk or sugar, and juices without pulp. Many Americans prefer to take their coffee with half and half or coffee creamer rather than black. This study will determine whether the addition of a small amount of cream to coffee makes any difference to the volume in the stomach after 2 hours.

This study will use healthy volunteers as study participants. Each participant will participate in the study 3 times with at least 2 days in between. We will use a bedside ultrasound machine to measure their stomach content volume at baseline and then they will consume one of 3 different prepare drinks - black coffee, coffee with half and half, or coffee with non-dairy coffee creamer. After 2 hours, we will scan their stomach again and measure stomach content volume and compare it to the first measurement. The participants will repeat this two more times on different days so that they would have had a chance to consume all three prepared coffee drinks in a random order.

02

Conditions studied

  • Anesthesia
  • Aspiration
  • Fasting
03

In context

Lead sponsor

University of Arkansas is the lead sponsor of 391 studies on the registry; 39 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 34 (92%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age between 18-65

Exclusion criteria

Exclusion Criteria:

  • Diabetes mellitus
  • Delayed gastric emptying
  • Previous gastric surgery
  • Lactose intolerance
  • Current pregnancy
  • Consumption of solid/liquids in 6 hours prior to commencement of ultrasound study
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
18 participants (actual)

Study arms

  • Placebo comparator
    Black coffee first

    12 oz of black coffee with no additives is the first intervention tested

    Other: Addition of half and half to coffee · Other: Addition of non-dairy creamer to coffee · Other: Black

  • Active comparator
    Coffee with half and half first

    12 oz of black coffee with 1 oz of half and half is the first intervention tested

    Other: Addition of half and half to coffee · Other: Addition of non-dairy creamer to coffee · Other: Black

  • Active comparator
    Coffee with non-dairy creamer first

    12 oz of black coffee with 1 oz of liquid non-dairy creamer is the first intervention tested

    Other: Addition of half and half to coffee · Other: Addition of non-dairy creamer to coffee · Other: Black

Interventions

  • OtherAddition of half and half to coffee

    1 oz of half and half is added to 12 oz of black coffee and given to participants assigned to this arm after the baseline gastric ultrasound

  • OtherAddition of non-dairy creamer to coffee

    1 oz of non-dairy creamer is added to 12 oz of black coffee and given to participants assigned to this arm after the baseline gastric ultrasound

  • OtherBlack

    No Creamer

06

What researchers measure

Primary outcomes

  1. Difference Between Gastric Volume Post Coffee Consumption Compared to the Baseline Gastric Volume

    Gastric volume calculated based on measured cross-sectional area (CSA) of gastric antrum and participant's age. CSA is measured at baseline after fasting for 6 hours and measured again 2 hours after consuming prepared coffee drink

    Time frame: Baseline 6 hours after fasting and 2 hours after intervention

07

Results

Posted Mar 23, 2023

Participant flow

First Intervention (2 Hours)
Participant flow — First Intervention (2 Hours)
Milestone1-Black Coffee, 2-half and Half, 3-creamer1-Black Coffee, 2-creamer, 3-half and Half1-half and Half, 2-black Coffee, 3-creamer1-half and Half, 2-creamer, 3-black Coffee1-creamer, 2-black Coffee, 3-half and Half1-creamer, 2-half and Half, 3-black Coffee
Started232434
Completed232434
Not completed000000
Washout Period (2 Days)
Participant flow — Washout Period (2 Days)
Milestone1-Black Coffee, 2-half and Half, 3-creamer1-Black Coffee, 2-creamer, 3-half and Half1-half and Half, 2-black Coffee, 3-creamer1-half and Half, 2-creamer, 3-black Coffee1-creamer, 2-black Coffee, 3-half and Half1-creamer, 2-half and Half, 3-black Coffee
Started232434
Completed232434
Not completed000000
Second Intervention (2 Hours)
Participant flow — Second Intervention (2 Hours)
Milestone1-Black Coffee, 2-half and Half, 3-creamer1-Black Coffee, 2-creamer, 3-half and Half1-half and Half, 2-black Coffee, 3-creamer1-half and Half, 2-creamer, 3-black Coffee1-creamer, 2-black Coffee, 3-half and Half1-creamer, 2-half and Half, 3-black Coffee
Started232434
Completed232434
Not completed000000
Washout Period (2 Days)
Participant flow — Washout Period (2 Days)
Milestone1-Black Coffee, 2-half and Half, 3-creamer1-Black Coffee, 2-creamer, 3-half and Half1-half and Half, 2-black Coffee, 3-creamer1-half and Half, 2-creamer, 3-black Coffee1-creamer, 2-black Coffee, 3-half and Half1-creamer, 2-half and Half, 3-black Coffee
Started232434
Completed232434
Not completed000000
Third Intervention (2 Hours)
Participant flow — Third Intervention (2 Hours)
Milestone1-Black Coffee, 2-half and Half, 3-creamer1-Black Coffee, 2-creamer, 3-half and Half1-half and Half, 2-black Coffee, 3-creamer1-half and Half, 2-creamer, 3-black Coffee1-creamer, 2-black Coffee, 3-half and Half1-creamer, 2-half and Half, 3-black Coffee
Started232434
Completed232434
Not completed000000

Outcome measures

PrimaryDifference Between Gastric Volume Post Coffee Consumption Compared to the Baseline Gastric Volume

Gastric volume calculated based on measured cross-sectional area (CSA) of gastric antrum and participant's age. CSA is measured at baseline after fasting for 6 hours and measured again 2 hours after consuming prepared coffee drink

Time frame:
Baseline 6 hours after fasting and 2 hours after intervention
Reported as:
Mean · milliliters
Difference Between Gastric Volume Post Coffee Consumption Compared to the Baseline Gastric Volume
millilitersBlack CoffeeCoffee With Half and HalfCoffee With Non-dairy Creamer
Difference Between Gastric Volume Post Coffee Consumption Compared to the Baseline Gastric Volume13 (-0.6 to 26.6)5 (-8.6 to 18.6)-1.5 (-15.1 to 12.1)

Adverse events

Collected over Adverse event data was collected over a 3 month period. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Black Coffee0/18 (0%)0/18 (0%)0/18 (0%)
Coffee With Half and Half0/18 (0%)0/18 (0%)0/18 (0%)
Coffee With Non-dairy Creamer0/18 (0%)0/18 (0%)0/18 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)All Study Participants
<=18 years0
Between 18 and 65 years18
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)All Study Participants
Female11
Male7
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)All Study Participants
Region of Enrollment
Region of Enrollment(participants)All Study Participants
United States18
Body Mass Index
Body Mass Index(kg/m^2)All Study Participants
Median22.4 (20.1 to 34.1)
08

Study locations

1 site
  • University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72211, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Dec 29, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04786691
Lead sponsor
University of Arkansas
Responsible party
Sponsor
First posted
Mar 8, 2021
Start date
Mar 1, 2021
Primary completion
Jun 30, 2021
Completion
Jun 30, 2021
Results posted
Mar 23, 2023
Last update
Mar 23, 2023

Study contacts

Jessica Yeh, MBBS
principal investigator · University of Arkansas

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion